In a recent publication,Gianatti and colleagues investigated the effect of testosterone treatment in obese,aging men with type 2 diabetes (T2D) with mild to moderate symptoms,a modest reduction in testosterone levels,mild to moderate aging male symptoms,and erectile dysfunction? The authors could not show any significant improvement in constitutional or sexual symptoms in this group of men.This randomized double-blind,parallel,and placebo-controlled trial among other critically emphasizes the increased testosterone prescriptions worldwide and together with other corroborating or contradictory studies awakes the need for guidelines in the androgen replacement treatment.